Gene: SLC16A14
Official Full Name: solute carrier family 16 member 14provided by HGNC
Gene Summary: Predicted to enable monocarboxylic acid transmembrane transporter activity. Predicted to be involved in carboxylic acid transmembrane transport. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21955 | SLC16A14 Knockout cell line (HeLa) | Human | SLC16A14 | 1:3~1:6 | Negative | Online Inquiry |
KO21956 | SLC16A14 Knockout cell line (HCT 116) | Human | SLC16A14 | 1:2~1:4 | Negative | Online Inquiry |
KO21957 | SLC16A14 Knockout cell line (HEK293) | Human | SLC16A14 | 1:3~1:6 | Negative | Online Inquiry |
KO21958 | SLC16A14 Knockout cell line (A549) | Human | SLC16A14 | 1:3~1:4 | Negative | Online Inquiry |
SLC16A14 Gene Knockout Cell Lines are genetically modified cellular systems that specifically lack the SLC16A14 gene, which encodes a member of the solute carrier family involved in monocarboxylate transport. These cell lines are pivotal tools for researchers investigating metabolism and transport mechanisms because they enable the study of the functional consequences of SLC16A14 deficiency. This gene is thought to play a significant role in various physiological processes, including lactate transport, energy metabolism, and cellular pH regulation, making these knockout lines invaluable for elucidating the specific pathways affected by its absence.
The primary function of SLC16A14 is to facilitate the transport of monocarboxylates, which are vital for energy production and metabolic balance. By utilizing these knockout cell lines, researchers can explore the downstream effects of SLC16A14 deletion on cellular metabolism and the physiological implications in model systems, contributing to a richer understanding of metabolic disorders and related pathologies. This can extend to the study of cancer metabolism, neuronal function, and metabolic syndromes, providing insights that could lead to novel therapeutic targets.
One of the key advantages of the SLC16A14 Gene Knockout Cell Lines is their specificity. Unlike conventional cell lines that may exhibit background expression of SLC16A14, these knockout models allow for precise evaluation of gene function and cellular responses without confounding factors. They also enable high-throughput screening for pharmacological agents that might restore normal function or mitigate the consequences of the knockout.
For researchers and clinicians, these cell lines represent a critical resource for advancing scientific knowledge and developing innovative strategies to address complex diseases. The SLC16A14 Gene Knockout Cell Lines are not only tools for investigation but also avenues for potential therapeutic discoveries.
With a robust background in genetic engineering and an unwavering commitment to scientific advancement, our company excels in providing high-quality biological products tailored for cutting-edge research. By choosing our products, you gain access to the latest innovations in the field, empowering your studies and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.